Research Summary
There is currently no known cure for ALS, but there are certain drugs used in the treatment of ALS that can help slow down the progression of the disease and relieve some of the symptoms. Some of the ALS treatment drugs include: 1. Riluzole: This is the only FDA-approved drug for the treatment of ALS. It helps to slow down the progression of the disease by reducing the levels of a neurotransmitter called glutamate. 2. Edaravone: This is another FDA-approved drug that is used to treat ALS. It works by reducing the damage caused by oxidative stress to nerve cells. 3. Baclofen: This is a muscle relaxant that is used to relieve muscle stiffness and spasms in people with ALS. 4. Gabapentin: This is an anticonvulsant drug that can be used to treat pain and muscle spasms in people with ALS. 5. Dextromethorphan: This is a cough suppressant that can be used to treat the excessive saliva production and coughing that occurs in people with ALS.
According to DIResearch's in-depth investigation and research, the global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Amyotrophic Lateral Sclerosis (ALS) Treatment Drug include Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Amyotrophic Lateral Sclerosis (ALS) Treatment Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Amyotrophic Lateral Sclerosis (ALS) Treatment Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Amyotrophic Lateral Sclerosis (ALS) Treatment Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Include:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Segment Include:
Riluzole
Edaravone (Radicava)
Other
Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Application Include:
Hospital
Drugs Store
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry PESTEL Analysis
Chapter 3: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product by Type 1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Riluzole 1.2.3 Edaravone (Radicava) 1.2.4 Other 1.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product by Application 1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital 1.3.3 Drugs Store 1.3.4 Other 1.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Revenue Analysis (2019-2030) 1.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Development Status and Trends 1.5.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry Development Status Analysis 1.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry Development Trends Analysis 2 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Analysis by Regions 4.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Revenue Forecast by Region (2025-2030) 5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type and Application 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 6 North America 6.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 6.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 6.5 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 7.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 7.5 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 8.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 9.4 APAC (excl. China) Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 9.5 APAC (excl. China) Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 10.4 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 10.5 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Type 11.4 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Application 11.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Revenue by Key Manufacturers (2020-2024) 12.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Mitsubishi Tanabe Pharma 13.1.1 Mitsubishi Tanabe Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Sanofi 13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Mylan Pharma 13.3.1 Mylan Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Apotex 13.4.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Glemark Generics 13.5.1 Glemark Generics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Covis Pharma 13.6.1 Covis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Sun Pharma 13.7.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Lunan Pharma 13.8.1 Lunan Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Product Portfolio 13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry Chain Analysis 14.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Typical Downstream Customers 14.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support